New Drug Approvals!
-Tremelimumab, the 2nd CTLA-4 inhibitor, finally gets approved.
-Teclistamab, an excited BCMA-CD3 T-cell engager for multiple myeloma.

No Room for MABs at the INN

OncoPharm is a podcast dedicated to all things oncology pharmacy.  Most episodes cover updates and recent publications concerning the use of medications in caring for patients we cancer.  Periodically, episodes drop devoted to Landmark Clinical Trials in oncology and Fundamentals of Oncology Pharmacy.